Immunostimulatory Adjuvants Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: IA6138078071EN
Market Monitor Global

Abstracts

Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature.

This report contains market size and forecasts of Immunostimulatory Adjuvants in global, including the following market information:

Global Immunostimulatory Adjuvants Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Immunostimulatory Adjuvants Market Sales, 2017-2022, 2023-2028, (K Pieces)

Global top five Immunostimulatory Adjuvants companies in 2021 (%)

The global Immunostimulatory Adjuvants market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Aluminum Hydroxide Adjuvant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immunostimulatory Adjuvants include Bayer, Adjuvance Technologies, Vical, Allergy Therapeutics and BioCentury, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunostimulatory Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immunostimulatory Adjuvants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immunostimulatory Adjuvants Market Segment Percentages, by Type, 2021 (%)

• Aluminum Hydroxide Adjuvant
• Alum Adjuvant
• Liposomes
• Others

Global Immunostimulatory Adjuvants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immunostimulatory Adjuvants Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Medical Centers
• Others

Global Immunostimulatory Adjuvants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immunostimulatory Adjuvants Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immunostimulatory Adjuvants revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immunostimulatory Adjuvants revenues share in global market, 2021 (%)

Key companies Immunostimulatory Adjuvants sales in global market, 2017-2022 (Estimated), (K Pieces)

Key companies Immunostimulatory Adjuvants sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Adjuvance Technologies
• Vical
• Allergy Therapeutics
• BioCentury

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immunostimulatory Adjuvants Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immunostimulatory Adjuvants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNOSTIMULATORY ADJUVANTS OVERALL MARKET SIZE

2.1 Global Immunostimulatory Adjuvants Market Size: 2021 VS 2028
2.2 Global Immunostimulatory Adjuvants Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immunostimulatory Adjuvants Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Immunostimulatory Adjuvants Players in Global Market
3.2 Top Global Immunostimulatory Adjuvants Companies Ranked by Revenue
3.3 Global Immunostimulatory Adjuvants Revenue by Companies
3.4 Global Immunostimulatory Adjuvants Sales by Companies
3.5 Global Immunostimulatory Adjuvants Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immunostimulatory Adjuvants Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immunostimulatory Adjuvants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immunostimulatory Adjuvants Players in Global Market
  3.8.1 List of Global Tier 1 Immunostimulatory Adjuvants Companies
  3.8.2 List of Global Tier 2 and Tier 3 Immunostimulatory Adjuvants Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Immunostimulatory Adjuvants Market Size Markets, 2021 & 2028
  4.1.2 Aluminum Hydroxide Adjuvant
  4.1.3 Alum Adjuvant
  4.1.4 Liposomes
  4.1.5 Others
4.2 By Type - Global Immunostimulatory Adjuvants Revenue & Forecasts
  4.2.1 By Type - Global Immunostimulatory Adjuvants Revenue, 2017-2022
  4.2.2 By Type - Global Immunostimulatory Adjuvants Revenue, 2023-2028
  4.2.3 By Type - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
4.3 By Type - Global Immunostimulatory Adjuvants Sales & Forecasts
  4.3.1 By Type - Global Immunostimulatory Adjuvants Sales, 2017-2022
  4.3.2 By Type - Global Immunostimulatory Adjuvants Sales, 2023-2028
  4.3.3 By Type - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
4.4 By Type - Global Immunostimulatory Adjuvants Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immunostimulatory Adjuvants Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Medical Centers
  5.1.4 Others
5.2 By Application - Global Immunostimulatory Adjuvants Revenue & Forecasts
  5.2.1 By Application - Global Immunostimulatory Adjuvants Revenue, 2017-2022
  5.2.2 By Application - Global Immunostimulatory Adjuvants Revenue, 2023-2028
  5.2.3 By Application - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
5.3 By Application - Global Immunostimulatory Adjuvants Sales & Forecasts
  5.3.1 By Application - Global Immunostimulatory Adjuvants Sales, 2017-2022
  5.3.2 By Application - Global Immunostimulatory Adjuvants Sales, 2023-2028
  5.3.3 By Application - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
5.4 By Application - Global Immunostimulatory Adjuvants Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immunostimulatory Adjuvants Market Size, 2021 & 2028
6.2 By Region - Global Immunostimulatory Adjuvants Revenue & Forecasts
  6.2.1 By Region - Global Immunostimulatory Adjuvants Revenue, 2017-2022
  6.2.2 By Region - Global Immunostimulatory Adjuvants Revenue, 2023-2028
  6.2.3 By Region - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
6.3 By Region - Global Immunostimulatory Adjuvants Sales & Forecasts
  6.3.1 By Region - Global Immunostimulatory Adjuvants Sales, 2017-2022
  6.3.2 By Region - Global Immunostimulatory Adjuvants Sales, 2023-2028
  6.3.3 By Region - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Immunostimulatory Adjuvants Revenue, 2017-2028
  6.4.2 By Country - North America Immunostimulatory Adjuvants Sales, 2017-2028
  6.4.3 US Immunostimulatory Adjuvants Market Size, 2017-2028
  6.4.4 Canada Immunostimulatory Adjuvants Market Size, 2017-2028
  6.4.5 Mexico Immunostimulatory Adjuvants Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Immunostimulatory Adjuvants Revenue, 2017-2028
  6.5.2 By Country - Europe Immunostimulatory Adjuvants Sales, 2017-2028
  6.5.3 Germany Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.4 France Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.5 U.K. Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.6 Italy Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.7 Russia Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.8 Nordic Countries Immunostimulatory Adjuvants Market Size, 2017-2028
  6.5.9 Benelux Immunostimulatory Adjuvants Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Immunostimulatory Adjuvants Revenue, 2017-2028
  6.6.2 By Region - Asia Immunostimulatory Adjuvants Sales, 2017-2028
  6.6.3 China Immunostimulatory Adjuvants Market Size, 2017-2028
  6.6.4 Japan Immunostimulatory Adjuvants Market Size, 2017-2028
  6.6.5 South Korea Immunostimulatory Adjuvants Market Size, 2017-2028
  6.6.6 Southeast Asia Immunostimulatory Adjuvants Market Size, 2017-2028
  6.6.7 India Immunostimulatory Adjuvants Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Immunostimulatory Adjuvants Revenue, 2017-2028
  6.7.2 By Country - South America Immunostimulatory Adjuvants Sales, 2017-2028
  6.7.3 Brazil Immunostimulatory Adjuvants Market Size, 2017-2028
  6.7.4 Argentina Immunostimulatory Adjuvants Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Immunostimulatory Adjuvants Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Immunostimulatory Adjuvants Sales, 2017-2028
  6.8.3 Turkey Immunostimulatory Adjuvants Market Size, 2017-2028
  6.8.4 Israel Immunostimulatory Adjuvants Market Size, 2017-2028
  6.8.5 Saudi Arabia Immunostimulatory Adjuvants Market Size, 2017-2028
  6.8.6 UAE Immunostimulatory Adjuvants Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Immunostimulatory Adjuvants Major Product Offerings
  7.1.4 Bayer Immunostimulatory Adjuvants Sales and Revenue in Global (2017-2022)
  7.1.5 Bayer Key News
7.2 Adjuvance Technologies
  7.2.1 Adjuvance Technologies Corporate Summary
  7.2.2 Adjuvance Technologies Business Overview
  7.2.3 Adjuvance Technologies Immunostimulatory Adjuvants Major Product Offerings
  7.2.4 Adjuvance Technologies Immunostimulatory Adjuvants Sales and Revenue in Global (2017-2022)
  7.2.5 Adjuvance Technologies Key News
7.3 Vical
  7.3.1 Vical Corporate Summary
  7.3.2 Vical Business Overview
  7.3.3 Vical Immunostimulatory Adjuvants Major Product Offerings
  7.3.4 Vical Immunostimulatory Adjuvants Sales and Revenue in Global (2017-2022)
  7.3.5 Vical Key News
7.4 Allergy Therapeutics
  7.4.1 Allergy Therapeutics Corporate Summary
  7.4.2 Allergy Therapeutics Business Overview
  7.4.3 Allergy Therapeutics Immunostimulatory Adjuvants Major Product Offerings
  7.4.4 Allergy Therapeutics Immunostimulatory Adjuvants Sales and Revenue in Global (2017-2022)
  7.4.5 Allergy Therapeutics Key News
7.5 BioCentury
  7.5.1 BioCentury Corporate Summary
  7.5.2 BioCentury Business Overview
  7.5.3 BioCentury Immunostimulatory Adjuvants Major Product Offerings
  7.5.4 BioCentury Immunostimulatory Adjuvants Sales and Revenue in Global (2017-2022)
  7.5.5 BioCentury Key News

8 GLOBAL IMMUNOSTIMULATORY ADJUVANTS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Immunostimulatory Adjuvants Production Capacity, 2017-2028
8.2 Immunostimulatory Adjuvants Production Capacity of Key Manufacturers in Global Market
8.3 Global Immunostimulatory Adjuvants Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IMMUNOSTIMULATORY ADJUVANTS SUPPLY CHAIN ANALYSIS

10.1 Immunostimulatory Adjuvants Industry Value Chain
10.2 Immunostimulatory Adjuvants Upstream Market
10.3 Immunostimulatory Adjuvants Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Immunostimulatory Adjuvants Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Immunostimulatory Adjuvants in Global Market
Table 2. Top Immunostimulatory Adjuvants Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immunostimulatory Adjuvants Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immunostimulatory Adjuvants Revenue Share by Companies, 2017-2022
Table 5. Global Immunostimulatory Adjuvants Sales by Companies, (K Pieces), 2017-2022
Table 6. Global Immunostimulatory Adjuvants Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immunostimulatory Adjuvants Price (2017-2022) & (USD/Piece)
Table 8. Global Manufacturers Immunostimulatory Adjuvants Product Type
Table 9. List of Global Tier 1 Immunostimulatory Adjuvants Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunostimulatory Adjuvants Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immunostimulatory Adjuvants Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immunostimulatory Adjuvants Sales (K Pieces), 2017-2022
Table 15. By Type - Global Immunostimulatory Adjuvants Sales (K Pieces), 2023-2028
Table 16. By Application – Global Immunostimulatory Adjuvants Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immunostimulatory Adjuvants Sales (K Pieces), 2017-2022
Table 20. By Application - Global Immunostimulatory Adjuvants Sales (K Pieces), 2023-2028
Table 21. By Region – Global Immunostimulatory Adjuvants Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immunostimulatory Adjuvants Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immunostimulatory Adjuvants Sales (K Pieces), 2017-2022
Table 25. By Region - Global Immunostimulatory Adjuvants Sales (K Pieces), 2023-2028
Table 26. By Country - North America Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immunostimulatory Adjuvants Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immunostimulatory Adjuvants Sales, (K Pieces), 2017-2022
Table 29. By Country - North America Immunostimulatory Adjuvants Sales, (K Pieces), 2023-2028
Table 30. By Country - Europe Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immunostimulatory Adjuvants Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immunostimulatory Adjuvants Sales, (K Pieces), 2017-2022
Table 33. By Country - Europe Immunostimulatory Adjuvants Sales, (K Pieces), 2023-2028
Table 34. By Region - Asia Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immunostimulatory Adjuvants Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immunostimulatory Adjuvants Sales, (K Pieces), 2017-2022
Table 37. By Region - Asia Immunostimulatory Adjuvants Sales, (K Pieces), 2023-2028
Table 38. By Country - South America Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immunostimulatory Adjuvants Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immunostimulatory Adjuvants Sales, (K Pieces), 2017-2022
Table 41. By Country - South America Immunostimulatory Adjuvants Sales, (K Pieces), 2023-2028
Table 42. By Country - Middle East & Africa Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immunostimulatory Adjuvants Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immunostimulatory Adjuvants Sales, (K Pieces), 2017-2022
Table 45. By Country - Middle East & Africa Immunostimulatory Adjuvants Sales, (K Pieces), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Immunostimulatory Adjuvants Product Offerings
Table 48. Bayer Immunostimulatory Adjuvants Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 49. Adjuvance Technologies Corporate Summary
Table 50. Adjuvance Technologies Immunostimulatory Adjuvants Product Offerings
Table 51. Adjuvance Technologies Immunostimulatory Adjuvants Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 52. Vical Corporate Summary
Table 53. Vical Immunostimulatory Adjuvants Product Offerings
Table 54. Vical Immunostimulatory Adjuvants Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 55. Allergy Therapeutics Corporate Summary
Table 56. Allergy Therapeutics Immunostimulatory Adjuvants Product Offerings
Table 57. Allergy Therapeutics Immunostimulatory Adjuvants Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 58. BioCentury Corporate Summary
Table 59. BioCentury Immunostimulatory Adjuvants Product Offerings
Table 60. BioCentury Immunostimulatory Adjuvants Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 61. Immunostimulatory Adjuvants Production Capacity (K Pieces) of Key Manufacturers in Global Market, 2020-2022 (K Pieces)
Table 62. Global Immunostimulatory Adjuvants Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Immunostimulatory Adjuvants Production by Region, 2017-2022 (K Pieces)
Table 64. Global Immunostimulatory Adjuvants Production by Region, 2023-2028 (K Pieces)
Table 65. Immunostimulatory Adjuvants Market Opportunities & Trends in Global Market
Table 66. Immunostimulatory Adjuvants Market Drivers in Global Market
Table 67. Immunostimulatory Adjuvants Market Restraints in Global Market
Table 68. Immunostimulatory Adjuvants Raw Materials
Table 69. Immunostimulatory Adjuvants Raw Materials Suppliers in Global Market
Table 70. Typical Immunostimulatory Adjuvants Downstream
Table 71. Immunostimulatory Adjuvants Downstream Clients in Global Market
Table 72. Immunostimulatory Adjuvants Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Immunostimulatory Adjuvants Segment by Type
Figure 2. Immunostimulatory Adjuvants Segment by Application
Figure 3. Global Immunostimulatory Adjuvants Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immunostimulatory Adjuvants Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immunostimulatory Adjuvants Revenue, 2017-2028 (US$, Mn)
Figure 7. Immunostimulatory Adjuvants Sales in Global Market: 2017-2028 (K Pieces)
Figure 8. The Top 3 and 5 Players Market Share by Immunostimulatory Adjuvants Revenue in 2021
Figure 9. By Type - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 10. By Type - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immunostimulatory Adjuvants Price (USD/Piece), 2017-2028
Figure 12. By Application - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 13. By Application - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immunostimulatory Adjuvants Price (USD/Piece), 2017-2028
Figure 15. By Region - Global Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 16. By Region - Global Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 19. US Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 24. Germany Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 25. France Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 33. China Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 37. India Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 40. Brazil Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immunostimulatory Adjuvants Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immunostimulatory Adjuvants Sales Market Share, 2017-2028
Figure 44. Turkey Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immunostimulatory Adjuvants Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immunostimulatory Adjuvants Production Capacity (K Pieces), 2017-2028
Figure 49. The Percentage of Production Immunostimulatory Adjuvants by Region, 2021 VS 2028
Figure 50. Immunostimulatory Adjuvants Industry Value Chain
Figure 51. Marketing Channels